Paid Clinical Trials Chattanooga
Discover 96 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Venetoclax with cBTKiA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.
Sponsor:
Genentech, Inc.
Location:
Code:
NCT06524375
Conditions
Chronic Lymphocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Venetoclax
cBTKi Monotherapy
DR-01A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Sponsor:
Dren Bio
Location:
Code:
NCT06602232
Conditions
Alopecia Areata
Vitiligo
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DR-01
BHV-7000A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Sponsor:
Biohaven Therapeutics Ltd.
Location:
Code:
NCT06425159
Conditions
Generalized Epilepsy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BHV-7000
Placebo
MelatoninDifferent Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
Sponsor:
Southeast Renal Research Institute
Location:
Code:
NCT01922999
Conditions
End Stage Renal Disease
Chronic Kidney Disease
Sleep Disorder
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Melatonin
Efgartigimod IVA Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
Sponsor:
argenx
Location:
Code:
NCT06298552
Conditions
Generalized Myasthenia Gravis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Efgartigimod IV
Placebo IV
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Observational StudyProspective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice
Sponsor:
Noah Medical
Location:
Code:
NCT06685133
Conditions
Lung Cancer
Lung; Nodule
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Robotic assisted bronchoscopy
Rilvegostomig & PembrolizumabA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Sponsor:
AstraZeneca
Location:
Code:
NCT06692738
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rilvegostomig
Pembrolizumab
Carboplatin
Paclitaxel
Nab-paclitaxel
Ifinatamab DeruxtecanA Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor:
Daiichi Sankyo
Location:
Code:
NCT06330064
Conditions
Recurrent or Metastatic Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ifinatamab deruxtecan
STaRTRegistry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Sponsor:
GT Medical Technologies, Inc.
Location:
Code:
NCT04427384
Conditions
Brain Tumor, Recurrent
Brain Tumor
Brain Tumor, Primary
Brain Tumor - Metastatic
Brain Tumor, Adult: Glioblastoma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
GammaTile
BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Sponsor:
Atea Pharmaceuticals, Inc.
Location:
Code:
NCT06868264
Conditions
HEPATITIS C VIRUS CHRONIC INFECTION
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bemnifosbuvir-Ruzasvir (BEM/RZR)
Sofosbuvir-Velpatasvir (SOF/VEL)